Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA04000068 | 4S-hydroperoxy-17S-HDHA | 4S-hydroperoxy-17S-hydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010177 | 10,13-diepi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010176 | 10,13-diepi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010305 | 10,13-diepi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010304 | 10,13-diepi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010245 | 10,17-diepi-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010244 | 10,17-diepi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010373 | 10,17-diepi-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010372 | 10,17-diepi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010183 | 10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010186 | 10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010311 | 10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010314 | 10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010175 | 10-epi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010178 | 10-epi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010303 | 10-epi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010306 | 10-epi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010249 | 10-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010248 | 10-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010377 | 10-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010376 | 10-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010169 | 10-epi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010168 | 10-epi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010297 | 10-epi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010296 | 10-epi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010199 | 11-D4c-NeuroP | 3-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010202 | 11-D4t-NeuroP | 3-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010327 | 11-E4c-NeuroP | 3-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010330 | 11-E4t-NeuroP | 3-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010191 | 11-epi-11-D4c-NeuroP | 3-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010194 | 11-epi-11-D4t-NeuroP | 3-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010319 | 11-epi-11-E4c-NeuroP | 3-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010322 | 11-epi-11-E4t-NeuroP | 3-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010209 | 13,16-diepi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010208 | 13,16-diepi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010337 | 13,16-diepi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010336 | 13,16-diepi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010261 | 13,20-diepi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010260 | 13,20-diepi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010389 | 13,20-diepi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010388 | 13,20-diepi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010215 | 13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010218 | 13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010343 | 13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010346 | 13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010185 | 13-epi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010184 | 13-epi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010313 | 13-epi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010312 | 13-epi-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010207 | 13-epi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010210 | 13-epi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010335 | 13-epi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010338 | 13-epi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010265 | 13-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010264 | 13-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010393 | 13-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010392 | 13-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010231 | 14-D4c-NeuroP | (Z)-6-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010234 | 14-D4t-NeuroP | (Z)-6-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010359 | 14-E4c-NeuroP | (Z)-6-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010362 | 14-E4t-NeuroP | (Z)-6-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010227 | 14-epi-14-D4c-NeuroP | (Z)-6-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010230 | 14-epi-14-D4t-NeuroP | (Z)-6-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010355 | 14-epi-14-E4c-NeuroP | (Z)-6-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010358 | 14-epi-14-E4t-NeuroP | (Z)-6-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010217 | 16-epi-13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010216 | 16-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010345 | 16-epi-13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010344 | 16-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010247 | 17-D4c-NeuroP | (4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010250 | 17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010375 | 17-E4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010378 | 17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010243 | 17-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010246 | 17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010371 | 17-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010374 | 17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010263 | 20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010266 | 20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010391 | 20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010394 | 20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010259 | 20-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010262 | 20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010387 | 20-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010390 | 20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010193 | 4,11-diepi-11-D4c-NeuroP | 3-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010192 | 4,11-diepi-11-D4t-NeuroP | 3-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010321 | 4,11-diepi-11-E4c-NeuroP | 3-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010320 | 4,11-diepi-11-E4t-NeuroP | 3-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010145 | 4,7-diepi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010144 | 4,7-diepi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010273 | 4,7-diepi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010272 | 4,7-diepi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010151 | 4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010154 | 4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010279 | 4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010282 | 4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010201 | 4-epi-11-D4c-NeuroP | 3-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010200 | 4-epi-11-D4t-NeuroP | 3-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010329 | 4-epi-11-E4c-NeuroP | 3-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010328 | 4-epi-11-E4t-NeuroP | 3-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010143 | 4-epi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010146 | 4-epi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010271 | 4-epi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010274 | 4-epi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010161 | 7,10-diepi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010160 | 7,10-diepi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010289 | 7,10-diepi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010288 | 7,10-diepi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010229 | 7,14-diepi-14-D4c-NeuroP | (Z)-6-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010228 | 7,14-diepi-14-D4t-NeuroP | (Z)-6-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010357 | 7,14-diepi-14-E4c-NeuroP | (Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010356 | 7,14-diepi-14-E4t-NeuroP | (Z)-6-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010167 | 7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010170 | 7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010295 | 7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010298 | 7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010233 | 7-epi-14-D4c-NeuroP | (Z)-6-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010232 | 7-epi-14-D4t-NeuroP | (Z)-6-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010361 | 7-epi-14-E4c-NeuroP | (Z)-6-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010360 | 7-epi-14-E4t-NeuroP | (Z)-6-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010153 | 7-epi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010152 | 7-epi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010281 | 7-epi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010280 | 7-epi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010159 | 7-epi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010162 | 7-epi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010287 | 7-epi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010290 | 7-epi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010309 | ent-10,13-diepi10-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010180 | ent-10,13-diepi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010181 | ent-10,13-diepi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010308 | ent-10,13-diepi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010240 | ent-10,17-diepi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010241 | ent-10,17-diepi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010368 | ent-10,17-diepi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010369 | ent-10,17-diepi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010174 | ent-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010171 | ent-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010302 | ent-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010299 | ent-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010182 | ent-10-epi-10-D4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010179 | ent-10-epi-10-D4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010310 | ent-10-epi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010307 | ent-10-epi-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010236 | ent-10-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010237 | ent-10-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010364 | ent-10-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010365 | ent-10-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010156 | ent-10-epi-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010157 | ent-10-epi-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010284 | ent-10-epi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010285 | ent-10-epi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010190 | ent-11-D4c-NeuroP | 3-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010187 | ent-11-D4t-NeuroP | 3-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010318 | ent-11-E4c-NeuroP | 3-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010315 | ent-11-E4t-NeuroP | 3-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010198 | ent-11-epi-11-D4c-NeuroP | 3-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010195 | ent-11-epi-11-D4t-NeuroP | 3-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010326 | ent-11-epi-11-E4c-NeuroP | 3-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010323 | ent-11-epi-11-E4t-NeuroP | 3-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010212 | ent-13,16-diepi-13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010213 | ent-13,16-diepi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010340 | ent-13,16-diepi-13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010341 | ent-13,16-diepi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010256 | ent-13,20-diepi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010257 | ent-13,20-diepi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010384 | ent-13,20-diepi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010385 | ent-13,20-diepi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010206 | ent-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010203 | ent-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010334 | ent-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010331 | ent-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010172 | ent-13-epi-10-D4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010173 | ent-13-epi-10-D4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010300 | ent-13-epi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010301 | ent-13-epi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010211 | ent-13-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010214 | ent-13-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010339 | ent-13-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010342 | ent-13-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010252 | ent-13-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010253 | ent-13-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010380 | ent-13-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010381 | ent-13-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010222 | ent-14-D4c-NeuroP | (Z)-6-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010219 | ent-14-D4t-NeuroP | (Z)-6-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010350 | ent-14-E4c-NeuroP | (Z)-6-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010347 | ent-14-E4t-NeuroP | (Z)-6-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010223 | ent-14-epi-14-D4t-NeuroP | (Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010226 | ent-14-epi-14-D4t-NeuroP | (Z)-6-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010351 | ent-14-epi-14-E4t-NeuroP | (Z)-6-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010354 | ent-14-epi-14-E4t-NeuroP | (Z)-6-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010204 | ent-16-epi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010205 | ent-16-epi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010332 | ent-16-epi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010333 | ent-16-epi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010238 | ent-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010235 | ent-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010366 | ent-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010363 | ent-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010242 | ent-17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010239 | ent-17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010370 | ent-17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010367 | ent-17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010254 | ent-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010251 | ent-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010382 | ent-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010379 | ent-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010258 | ent-20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010255 | ent-20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010386 | ent-20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010383 | ent-20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010196 | ent-4,11-diepi-11-D4c-NeuroP | 3-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010197 | ent-4,11-diepi-11-D4t-NeuroP | 3-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010324 | ent-4,11-diepi-11-E4c-NeuroP | 3-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010325 | ent-4,11-diepi-11-E4t-NeuroP | 3-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010148 | ent-4,7-diepi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010149 | ent-4,7-diepi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010276 | ent-4,7-diepi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010277 | ent-4,7-diepi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010142 | ent-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010139 | ent-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010270 | ent-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010267 | ent-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010188 | ent-4-epi-11-D4c-NeuroP | 3-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010189 | ent-4-epi-11-D4t-NeuroP | 3-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010316 | ent-4-epi-11-E4c-NeuroP | 3-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010317 | ent-4-epi-11-E4t-NeuroP | 3-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010150 | ent-4-epi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010147 | ent-4-epi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010278 | ent-4-epi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010275 | ent-4-epi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010164 | ent-7,10-diepi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010165 | ent-7,10-diepi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010292 | ent-7,10-diepi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010293 | ent-7,10-diepi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010224 | ent-7,14-diepi-14-D4c-NeuroP | (Z)-6-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010225 | ent-7,14-diepi-14-D4t-NeuroP | (Z)-6-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010352 | ent-7,14-diepi-14-E4c-NeuroP | (Z)-6-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010353 | ent-7,14-diepi-14-E4t-NeuroP | (Z)-6-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010158 | ent-7-D4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010155 | ent-7-D4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010286 | ent-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010283 | ent-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010220 | ent-7-epi-14-D4c-NeuroP | (Z)-6-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010221 | ent-7-epi-14-D4t-NeuroP | (Z)-6-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010348 | ent-7-epi-14-E4c-NeuroP | (Z)-6-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010349 | ent-7-epi-14-E4t-NeuroP | (Z)-6-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010140 | ent-7-epi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010141 | ent-7-epi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010268 | ent-7-epi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010269 | ent-7-epi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010166 | ent-7-epi-7-D4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010163 | ent-7-epi-7-D4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010294 | ent-7-epi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04010291 | ent-7-epi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030005 | AT-Resolvin D1 | 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030006 | AT-Resolvin D2 | 7S,16R,17R-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030008 | AT-Resolvin D3 | 4S,11,17R- trihydroxy-5E,7E,9E,13Z,15E,19Z-docosahexaenoic-acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030007 | AT-Resolvin D4 | 4S,5,17R-trihydroxy-6E,8E,10E,13E,15Z,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030011 | Resolvin D1 | 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030001 | Resolvin D2 | 7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030012 | Resolvin D3 | 4S,10,17S-trihydroxy-5E,7E,9E,13Z,15E,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
| LMFA04030002 | Resolvin D4 | 4S,5,17S-trihydroxy-6E,8E,10E,13E,15Z,19Z-docosahexaenoic acid | Docosanoids [FA04] | - | 376.22 | C22H32O5 |
Download LMSD record summary for FA 22:6;O3